23andMe, the Food and Drug Administration, and the future of genetic testing
On November 22, 2013, the US Food and Drug Administration (FDA) effectively halted
health-related directto-consumer genetic testing in the United States by sending a warning
letter to 23andMe, the leading company in the field, directing it to stop providing such testing.
1 The FDA acted as the era of widespread, clinical use of DNA sequencing rapidly
approaches. The agency's action will contribute to changes in which genetic tests are
offered to patients and how testing is provided. Since 2007, Mountain View, California …
health-related directto-consumer genetic testing in the United States by sending a warning
letter to 23andMe, the leading company in the field, directing it to stop providing such testing.
1 The FDA acted as the era of widespread, clinical use of DNA sequencing rapidly
approaches. The agency's action will contribute to changes in which genetic tests are
offered to patients and how testing is provided. Since 2007, Mountain View, California …
以上显示的是最相近的搜索结果。 查看全部搜索结果